Raymond Anderson insider trades

Open-market stock purchases and sales by Raymond Anderson, Director at Monopar Therapeutics, from SEC Form 4 filings since Mar 9, 2010.

Recent trades

DateStockTradeValue
Aug 25, 2026MNPR Monopar TherapeuticsSold$76.4K
Aug 25, 2026MNPR Monopar TherapeuticsSold$71.1K
Aug 25, 2026MNPR Monopar TherapeuticsSold$204K
Aug 25, 2026MNPR Monopar TherapeuticsSold$76.4K
Aug 25, 2026MNPR Monopar TherapeuticsSold$71.8K
Aug 25, 2026MNPR Monopar TherapeuticsSold$204K
Aug 25, 2026MNPR Monopar TherapeuticsBought (not open market)$42.1K
Aug 25, 2026MNPR Monopar TherapeuticsBought (not open market)$52.2K
Aug 25, 2026MNPR Monopar TherapeuticsBought (not open market)—
Aug 25, 2026MNPR Monopar TherapeuticsBought (not open market)—
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: 6 sales, last Aug 25, 2026
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018
  • RPTP Raptor Pharmaceutical Corp: 23 sales, last Oct 25, 2016

Get free alerts when Raymond Anderson files a new trade →